OUR STORY (7.11) REGENERAGE LIFE
We have built on research based on a 2012 Nobel Prize award that allows us to fight the underlying cause of aging skin, instead of simply treating the effects. We have found a way to awaken youthful cell memories back to their active and healthy lifestyle, leading to younger and more vivacious skin. Our customers deserve the purest and highest quality ingredients, and that’s exactly what our unique formula delivers.
The result of years of hard work and research, Bioquantine® is a unique formula designed to reverse the aging process. Bioquantine® is a patented, all-natural bioactive extract used only in FDA certified formulations. This incredible extract includes over 90 polypeptides, which are proteins used to repair damaged human DNA and cells. By utilizing this formula, we have actually found a way to reprogram damaged cells to repair themselves back into a healthy and youthful state. While most skincare products on the market only affect the top layer of skin, ours actually penetrates down to the second layer to heal and regenerate damaged cells.All this, from a natural extract!
Peptides have been a core ingredient in the global skincare industry for quite some time. They are powerful proteins used to repair damaged cells, and their benefits have been proven in clinical trials. However, most skincare products have an average of only two or three peptides in their formula, while our Bioquantine® formula contains 94! This blend of natural elements is how we differentiate ourselves.We believe health and beauty go hand in hand and will always ensure wellness for years to come.
Mr. Ira Pastor, MBA
Ira has over 30 years of experience across multiple sectors of the pharmaceutical industry, including pharmaceutical commercialization, biotech drug development, managed care, distribution, OTC, and retail. He served as Vice President of Business Development for drug development company Phytomedics Inc., raising $40 million of private equity, consummating over $50 million of licensing deals, and bringing lead drug candidate from discovery stage to Phase III development.
Prior to that, Ira was employed by SmithKline Beecham Pharmaceuticals working in sales, marketing, and business strategy positions. Mr. Pastor has also served as Vice President of Corporate Development for the pharmacy benefit management company Prescription Delivery Systems (acquired by Cigna Health Insurance). Ira has received his MBA from Temple University and his BS in Pharmacy from Rutgers University.
He is currently the Longvevity and Aging Ambassador for the IdeaXme Show. He is also a Board Member of RegenerAge SAPI de CV, a clinical company focused on expedited translational therapeutic applications of regenerative and rejuvenative healthcare interventions, the Reanima Project, and member of the World Economic Forum’s Human Enhancement council.
Dr. Sergei Paylian, PhD
Dr. Sergei Paylian has over 30 years of extensive research and administrative experience in the biomedical sciences including: molecular biology, genetics, immunology, immunohistochemistry, virology, experimental gerontology, oncology, pharmacology, microbiology, physiology, electrophysiology, and stem cell biology.
He has developed breakthrough technology in human somatic cell reprogramming (U.S. Patents pending), as well as precursor microincubator technology (Use of Xenopus laevis oocytes as microincubators – U.S. Patent #7,135,336). He has held various academic research institute positions including: Department of Veterinary Medicine, University of Illinois, Urbana-Champaign, Illinois; College of Medicine, Bio-Sciences Department and Department of Pharmacology, University of South Florida, Tampa, Florida. Department of Pediatrics, Division of Pulmonary Medicine, University of Wisconsin, Madison. University of Illinois at Chicago, Chicago – MS, Ph.D (Hon) in Biophysics, Bogomolets Institute of Physiology, Kiev, Ukraine; MS in Physics, Biology and Chemistry, and Department of Physical Science, Tbilisi State University, Republic of Georgia.
He is also a Board Member of RegenerAge SAPI de CV, a clinical company focused on expedited translational therapeutic applications of regenerative and rejuvenative healthcare interventions, and the Reanima Project.
Dr. Joel I. Osorio, MD
Dr. Joel I. Osorio is an innovative businessman with a distinct entrepreneurial mindset concentrated in adding value on the areas of Biotechnology (mRNA), Reprogramming & Regenerative Medicine for translational use in humans and a variety of clinical applications aimed for both the private and the public health sectors.
He is the CEO of RegenerAge Clinic and RegenerAge Life Initiatives. He is VP and Clinical Developer for Bioquark,Inc. and President at Dr. Jois®️, an anti-aging, beauty and cosmetic products endorsement company. He is also VP and Chairman of the WAMS Americas Division. He has earned MD degree at Westhill University, Diplomate in aesthetic medicine (UAG), Advance Fellow by the ABAARM, visiting scholar at UNC at Chapel Hill in Dermatology, fellow in Stem Cell Medicine by the A4M and USF, Business Diplomate at ECA, and enrolled Master on Health Sciences at Victoria University.
Dr. Osorio has concentrated most of his career on biotechnology and regenerative medicine, and has conducted over 7,000 BioActivated PRP’s procedures while working in several stem cell clinics. He is an expert in the use of antioxidants and has given over 700 stem cell treatments for anti-aging purposes.
He has appeared, on several occasions, on International media. Some of his latest broadcast appearances are CNN español, TV Azteca, Excelsior Newspaper, Medicable, PharmaBoard Room, and Podcasts among others.